SQZ Biotechnologies Quick Ratio 2020-2022 | SQZ
Historical quick ratio values for SQZ Biotechnologies (SQZ) over the last 10 years.
| SQZ Biotechnologies Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2022-12-31 |
$0.00B |
$0.02B |
0.00 |
| 2022-09-30 |
$0.00B |
$0.03B |
0.00 |
| 2022-06-30 |
$0.00B |
$0.03B |
0.00 |
| 2022-03-31 |
$0.00B |
$0.03B |
0.00 |
| 2021-12-31 |
$0.00B |
$0.03B |
0.00 |
| 2021-09-30 |
$0.00B |
$0.04B |
0.00 |
| 2021-06-30 |
$0.00B |
$0.04B |
0.00 |
| 2021-03-31 |
$0.00B |
$0.04B |
0.00 |
| 2020-12-31 |
$0.00B |
$0.05B |
0.00 |
| 2020-09-30 |
$0.00B |
$0.05B |
0.00 |
| 2020-06-30 |
$0.00B |
|
0.00 |
| 2020-03-31 |
$0.00B |
|
0.00 |
| 2019-12-31 |
$0.00B |
|
0.00 |
| 2019-09-30 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.024B |
$0.021B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
